EIF2A and breast cancer: Next, we assessed the protein levels of PERK and its downstream phospho-PERK and phospho-eIF2α inRHBDF1-knockout MCF-7 and 4T1 breast cancer cells overexpressing C-terminal HA-tagged RHBDF1.